Amarin Corp Plcuk (AMRN) Inventory (2012 - 2026)
Amarin Corp Plcuk (AMRN) reported Inventory of $183.6 million for Q1 2026, up 15.12% year-over-year from $159.5 million in Q1 2025, and down 6.28% quarter-over-quarter from $195.9 million in Q4 2025.
Amarin Corp Plcuk (AMRN) Inventory (2012 - 2026) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 15 years of Inventory data on file, last reported at $183.6 million in Q1 2026.
- Inventory for Q1 2026 came in at $183.6 million, up 15.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $183.6 million (up 15.12% YoY), and the FY2025 annual result was $195.9 million, up 17.98% from the prior year.
- Inventory declined to $183.6 million in Q1 2026 per AMRN's latest filing, from $195.9 million in the prior quarter.
- Over five years, Inventory peaked at $267.8 million in Q1 2022 and troughed at $159.5 million in Q1 2025.
- A 5-year average of $217.4 million and a median of $225.8 million in 2023 frame the typical range for Inventory.
- On a YoY basis, Inventory climbed as much as 17.98% in 2025 and fell as far as 37.52% in 2025.
- A 5-year view of Inventory shows it stood at $228.7 million in 2022, then rose by 13.07% to $258.6 million in 2023, then sank by 35.79% to $166.0 million in 2024, then gained by 17.98% to $195.9 million in 2025, then slipped by 6.28% to $183.6 million in 2026.
- Business Quant data shows AMRN's Inventory at $183.6 million in Q1 2026, $195.9 million in Q4 2025, and $184.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | 8.30 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 14.53 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 14.58 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 5.05 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 6.48 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 6.19 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 1.91 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 10.67 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 2.76 Bn |
| 10 | Amarin Corp Plcuk | 5.84 Bn | 5.66 Bn | 17.77 Mn | 183.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183.60 Mn |
| Dec 31, 2025 | 195.91 Mn |
| Sep 30, 2025 | 184.70 Mn |
| Jun 30, 2025 | 171.20 Mn |
| Mar 31, 2025 | 159.49 Mn |
| Dec 31, 2024 | 166.05 Mn |
| Sep 30, 2024 | 224.00 Mn |
| Jun 30, 2024 | 239.40 Mn |
| Mar 31, 2024 | 255.28 Mn |
| Dec 31, 2023 | 258.62 Mn |
| Sep 30, 2023 | 254.50 Mn |
| Jun 30, 2023 | 227.02 Mn |
| Mar 31, 2023 | 225.81 Mn |
| Dec 31, 2022 | 228.73 Mn |
| Sep 30, 2022 | 227.60 Mn |
| Jun 30, 2022 | 225.80 Mn |
| Mar 31, 2022 | 267.82 Mn |
| Dec 31, 2021 | 234.68 Mn |
| Sep 30, 2021 | 309.30 Mn |
| Jun 30, 2021 | 272.50 Mn |